Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2020

Dec 17, 2020

30786_dirs_2020-12-17_c829baac-6595-46a1-b709-06f4cf961b94.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2020-12-15

Reporting Person: Crowley Michael (EVP, GBL Commercial Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-15 Bio-Rad A Common Stock S 374 $580.67 Disposed 3669 Direct